12.3 Exceptions and Conditions Prohibiting Dispensing

When the correct answer is “do not fill”

Quick Answer: Do not dispense a forged or altered prescription, a Schedule II refill, an out-of-scope order, adulterated stock, a Class I recalled lot in active inventory, a controlled substance to a person not known without photographic ID (CGS § 20-612a), a first-fill opioid that clearly violates CGS § 20-14o without a documented exception, or an emergency oral CII whose covering prescription was not mailed or delivered within 72 hours (CGS § 21a-249). Two statutes allow limited dispensing without a new prescriber order: § 20-616(c) (one 72-hour noncontrolled emergency refill) and § 20-616(d) (pharmacist-prescribed 30-day insulin, glucagon, or ketoacidosis devices, with 72-hour notice to the last prescriber).

NABP Competencies 3.4 (exceptions) and 3.7 (conditions prohibiting dispensing) are the same afternoon at a Connecticut bench. Section 12.1 is the judgment call when the blank looks real but the purpose does not. This section is the hard stops and the narrow doors that Chapter 400j actually wrote. Do not confuse the 72-hour emergency noncontrolled refill with the 72-hour covering-prescription clock for oral CII or the 72-hour notice after a pharmacist-prescribed insulin supply. Three different 72-hour sentences, three different jobs.

Hard stops — conditions that prohibit dispensing

Forgery and alteration. A photocopied, traced, or quantity-changed CII is not a prescription. Authenticate with the prescriber. If the prescriber did not write it, do not fill, do not “change it back to 30 and fill,” and do not hand it back so the patient can try the next store without documenting the event. That is § 20-579(a)(5) territory if you release it.

Expired controlled-substance prescriptions versus expired product. CGS § 21a-249(h) is specific to Schedule III and IV: not filled or refilled more than six months after the date thereof, and not refilled more than five times, unless renewed. Schedule V is a medical-purpose drug under § 21a-249(i) (Chapter 9). Schedule II has no published Connecticut fill-by day count in § 21a-249 and no federal numeric expiration in 21 CFR 1306. Do not import another state’s “30-day CII” rule. Do not fill a six-month-old oxycodone for acute dental pain as if nothing had changed—1306.04 still asks whether it remains in the usual course of care. Expired product is a different prohibition: once the labeled expiration has passed, holding it in the active bay is adulteration (21 U.S.C. § 351, Chapter 6.1).

Identity. CGS § 20-612a requires a pharmacist or the pharmacist’s agent to require valid photographic identification before releasing a controlled substance to any person not known to that pharmacist. The section does not apply in an institutional setting or to a long-term care facility, including, but not limited to, an assisted living setting. A known long-time patient of the pharmacist is not the statutory trigger. A stranger picking up oxycodone is. No ID when ID is required means do not release.

Class I recall. Class I means a reasonable probability of serious adverse health consequences or death (Chapter 6.2). Matching lots in robots, will-call, and the fast-mover bay are quarantined. Dispensing a Class I lot that is still in active stock is a quality failure and an adulteration/misbranding problem. Class II and III follow the firm’s notice; they are not a license to ignore Class I.

Opioid first-fill. CGS § 20-14o(b) limits an adult’s first-time outpatient opioid to a 7-day supply. § 20-14o(c) limits an opioid issued to a minor to a 5-day supply. Subsection (d) lets the practitioner exceed those numbers for a documented acute condition, chronic pain, cancer-associated pain, or palliative care, with a note that an alternative was not appropriate. A 30-day oxycodone for uncomplicated dental extraction, no (d) documentation, first outpatient fill, is not a “maybe.” Corresponding responsibility says do not fill as written. Calling the dentist for a 7-day quantity, or refusing, is the legal path. A documented palliative 30-day opioid is the exception the statute wrote—do not invent a “Connecticut never allows more than 7 days” rule (Chapter 9.3).

Emergency oral CII covering prescription. Federally the covering prescription may be postmarked within 7 days (21 CFR 1306.11(d)). CGS § 21a-249 requires mailing or delivery within 72 hours. 72 hours wins in Connecticut. If the covering prescription never arrives, the pharmacist notifies the nearest DEA office; failure to notify voids the authority to have dispensed. You do not keep filling from the oral note on day four.

Narrow doors — exceptions that allow dispensing

Chapter 400j writes two doors that are not corresponding-responsibility loopholes for oxycodone.

CGS § 20-616(c) — emergency refill of a noncontrolled prescription. All of the following must be true:

• The prescription is not for a controlled drug
• After reasonable effort, the pharmacist cannot contact the practitioner
• Failure to refill might interrupt a therapeutic regimen or create patient suffering
• The pharmacist tells the patient at dispensing that the fill is unauthorized, and tells the practitioner at the earliest reasonable time that authorization is required for future refills

Then the prescription may be refilled once, for not more than a 72-hour supply. It is not a 30-day courtesy, not available for clonazepam, and not a remaining-refill generator.

CGS § 20-616(d) — pharmacist-prescribed diabetes supply. This is a new pharmacist prescription, not a refill of the old one, and it is not hidden in § 20-633 (immunization). DCP’s November 3, 2025 page and § 20-616(d) allow a pharmacist to immediately prescribe and dispense not more than a 30-day supply of a diabetic ketoacidosis device, insulin drug, or glucagon drug, plus devices needed to administer that supply, when:

• The patient reports less than a 7-day supply
• The pharmacist determines the patient will likely suffer significant physical harm within seven days without an additional supply
• The pharmacist reviews CPMRS and determines no pharmacist has prescribed and dispensed such a supply to that patient within the last year (and contacts the pharmacy that filled the most recent prescription as needed to confirm)
• Not later than 72 hours after dispensing, the pharmacist or representative notifies the practitioner who most recently prescribed the product

§ 20-616(d)(1)(B) then uses shall: if those criteria are met and the patient pays or has health insurance coverage for the product, the pharmacist shall prescribe and dispense. The 72 hours here is notice to the prescriber, not a 72-hour supply. Do not mix it with § 20-616(c).

• Noncontrolled, office closed, 72-hour bottle → § 20-616(c)
• Insulin almost gone, 30-day pharmacist Rx, 72-hour call to the last prescriber → § 20-616(d)
• Oxycodone → neither door

Scenario: Saturday hard stops and one lawful exception

A Bridgeport Saturday shift sees five requests. (1) A cash stranger wants oxycodone and has no photo ID — § 20-612a, do not release. (2) A first-fill adult dental oxycodone for 30 days with no § 20-14o(d) note — refuse as written and call. (3) A CII “refill” sticker on last month’s oxycodone — never. (4) A Class I lot of an injectable still in the robot — quarantine, do not dispense. (5) A lisinopril patient with no remaining refills, office closed, missed doses would interrupt therapy — one 72-hour noncontrolled supply under § 20-616(c). An insulin patient with two days of analog left, significant harm likely this week, CPMRS showing no pharmacist-issued diabetes supply in the past year, and insurance that will pay, is the § 20-616(d) shall-dispense 30-day path, with notice to the last prescriber within 72 hours. Mixing those five into “we always help on weekends” is how the MPJE separates a pharmacist from a clerk.

CT may be stricter; more-restrictive wins.

Official anchors

• 21 CFR 1306.04 and 1306.11 — illegitimate orders; emergency oral CII covering prescription.
• CGS § 21a-249 — CII no refills; 72-hour covering prescription; CIII–IV six-month / five-refill cap.
• CGS § 20-14o — 7-day / 5-day opioid defaults and subsection (d) exceptions.
• CGS §§ 20-612a, 20-616 — CS photo ID; 72-hour noncontrolled emergency refill; 30-day pharmacist-prescribed insulin/glucagon/DKA devices.
• DCP diabetic drugs and devices — current 30-day criteria and 72-hour prescriber notice (updated November 3, 2025).